Dr. Charles Smith, M.D

Neurology La Jolla, CA Male
NPI: 1700959426
Total Payments
$590,505
2023 Payments
$28,857
Companies
62
Transactions
1,312
Medicare Patients
1,459
Medicare Billing
$314,089

Payment Breakdown by Category

Other$420,220 (71.2%)
Consulting$99,499 (16.8%)
Travel$45,222 (7.7%)
Food & Beverage$24,978 (4.2%)
Education$586.51 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $401,285 155 68.0%
Consulting Fee $99,499 24 16.8%
Travel and Lodging $45,222 142 7.7%
Food and Beverage $24,978 974 4.2%
Honoraria $18,935 4 3.2%
Education $586.51 13 0.1%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $188,825 216 $0 (2023)
EMD Serono, Inc. $102,644 165 $0 (2023)
GENZYME CORPORATION $86,248 89 $0 (2023)
Genentech USA, Inc. $51,038 59 $0 (2023)
Horizon Therapeutics plc $35,092 60 $0 (2023)
Novartis Pharmaceuticals Corporation $34,830 172 $0 (2023)
Celgene Corporation $27,327 73 $0 (2023)
Alexion Pharmaceuticals, Inc. $17,323 38 $0 (2023)
Teva Pharmaceuticals USA, Inc. $14,731 58 $0 (2023)
E.R. Squibb & Sons, L.L.C. $11,259 13 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $28,857 142 EMD Serono, Inc. ($17,707)
2022 $77,586 170 Biogen, Inc. ($26,590)
2021 $36,269 120 Biogen, Inc. ($14,797)
2020 $57,940 110 Biogen, Inc. ($27,163)
2019 $145,215 305 Biogen, Inc. ($37,671)
2018 $121,387 230 Biogen, Inc. ($47,823)
2017 $123,251 235 Biogen, Inc. ($34,569)

All Payment Transactions

1,312 individual payment records from CMS Open Payments — Page 1 of 53

Date Company Product Nature Form Amount Type
12/18/2023 EMD Serono, Inc. — Food and Beverage Cash or cash equivalent $39.81 General
12/18/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $22.05 General
Category: BOTOX THERAPEUTIC
12/11/2023 Horizon Therapeutics plc UPLIZNA (Drug) Honoraria Cash or cash equivalent $3,300.00 General
Category: UPLIZNA
12/11/2023 Horizon Therapeutics plc UPLIZNA (Drug) Food and Beverage In-kind items and services $148.59 General
Category: UPLIZNA
12/04/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $12.34 General
Category: Neuroscience
11/30/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $31.28 General
Category: Neurology
11/16/2023 EMD Serono, Inc. MAVENCLAD (Drug) Food and Beverage Cash or cash equivalent $17.02 General
Category: Neurology
11/16/2023 EMD Serono, Inc. MAVENCLAD (Drug) Food and Beverage Cash or cash equivalent $14.33 General
Category: Neurology
11/15/2023 AbbVie Inc. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $17.65 General
Category: NEUROSCIENCE
11/06/2023 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.56 General
Category: PAIN
11/02/2023 Alexion Pharmaceuticals, Inc. SOLIRIS (Biological) Food and Beverage In-kind items and services $25.55 General
Category: Rare Disease
11/02/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $10.54 General
Category: Neuroscience
10/30/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $13.64 General
Category: NEUROSCIENCE
10/27/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $7.50 General
Category: Neuroscience
10/26/2023 EMD Serono, Inc. MAVENCLAD (Drug) Food and Beverage Cash or cash equivalent $14.50 General
Category: Neurology
10/20/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $5.50 General
Category: Neuroscience
10/19/2023 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $20.07 General
Category: Neurology
10/12/2023 BANNER LIFE SCIENCES, LLC BAFIERTAM (Drug) Food and Beverage In-kind items and services $18.19 General
Category: Immune
10/09/2023 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $16.77 General
Category: PAIN
10/09/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $12.10 General
Category: Neuroscience
10/04/2023 EMD Serono, Inc. MAVENCLAD (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,175.00 General
Category: Neurology
10/04/2023 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $23.13 General
Category: NEUROLOGY
09/28/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $19.31 General
Category: Neurology
09/27/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $13.86 General
Category: Neuroscience
09/25/2023 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $18.70 General
Category: Neurology
123…53»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 300 10,725 $382,065 $91,879
2022 8 383 7,694 $359,663 $90,259
2021 8 393 6,900 $337,655 $87,502
2020 7 383 432 $158,169 $44,449
Total Patients
1,459
Total Services
25,751
Medicare Billing
$314,089
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 22 10,350 $225,320 $50,595 22.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 158 209 $73,213 $20,763 28.4%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 22 64 $36,998 $8,164 22.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 38 38 $17,209 $4,967 28.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 34 38 $18,669 $4,914 26.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 12 12 $7,178 $1,698 23.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 14 14 $3,478 $778.07 22.4%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 18 7,250 $157,833 $34,909 22.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 171 220 $77,074 $22,283 28.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 77 77 $34,851 $10,015 28.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 48 50 $24,536 $6,840 27.9%
95816 Measurement of brain wave activity (eeg), awake and drowsy Office 2022 17 17 $22,824 $6,009 26.3%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2022 17 45 $26,520 $5,874 22.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 21 21 $12,549 $3,594 28.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 14 14 $3,476 $736.83 21.2%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2021 15 6,450 $136,840 $30,813 22.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 156 192 $67,072 $19,402 28.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 96 96 $43,120 $13,065 30.3%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 45 53 $25,718 $7,463 29.0%
95816 Measurement and recording of brain wave (eeg) activity, awake and drowsy Office 2021 19 19 $24,829 $6,594 26.6%
64615 Injection of chemical for destruction of facial and neck nerve muscles on both sides of face Office 2021 15 41 $23,220 $5,333 23.0%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 14 14 $8,250 $2,450 29.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 33 35 $8,607 $2,383 27.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 152 191 $56,202 $14,683 26.1%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 92 92 $40,590 $11,802 29.1%
12»

About Dr. Charles Smith, M.D

Dr. Charles Smith, M.D is a Neurology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700959426.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Smith, M.D has received a total of $590,505 in payments from pharmaceutical and medical device companies, with $28,857 received in 2023. These payments were reported across 1,312 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($401,285).

As a Medicare-enrolled provider, Smith has provided services to 1,459 Medicare beneficiaries, totaling 25,751 services with total Medicare billing of $314,089. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Neurology
  • Location La Jolla, CA
  • Active Since 11/17/2006
  • Last Updated 06/29/2009
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1700959426

Products in Payments

  • TYSABRI (Biological) $102,784
  • AUBAGIO (Drug) $44,509
  • OCREVUS (Biological) $44,258
  • LEMTRADA (Drug) $41,771
  • Mavenclad (Biological) $36,674
  • TECFIDERA (Drug) $35,928
  • UPLIZNA (Drug) $35,092
  • Mavenclad (Drug) $26,450
  • ZEPOSIA (Drug) $23,011
  • VUMERITY (Drug) $22,019
  • Rebif (Biological) $20,538
  • GILENYA (Drug) $18,226
  • MAVENCLAD (Drug) $17,146
  • COPAXONE (Drug) $14,461
  • Ozanimod (Drug) $9,818
  • Non-Covered Product (Drug) $7,915
  • AMPYRA (Drug) $6,264
  • ZINBRYTA (Biological) $5,764
  • MAYZENT (Drug) $5,565
  • ACTHAR (Biological) $5,233

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in La Jolla

Dr. Jody Corey-Bloom, Md, Phd, MD, PHD

Neurology — Payments: $452,305

Neurology $452,305

Dr. Jay Rosenberg, M.d, M.D

Neurology — Payments: $216,627

Neurology $216,627

Dr. Christy Jackson, M.d, M.D

Neurology — Payments: $213,127

Neurology $213,127

Dr. Emily Engel, M.d, M.D

Neurology — Payments: $151,871

Neurology $151,871

Dr. Dee Silver, Md, MD

Neurology — Payments: $103,830

Neurology $103,830

Dr. Douglas Galasko, Md, MD

Neurology — Payments: $76,399

Neurology $76,399